Click to view our statement on Accessibility

Suggested Searches

    Popular Searches

    Back
    Events

    HCCA 17th Annual Compliance Institute

    April 21, 2013

    People

    Nathaniel Lacktman headshot.

    Nathaniel M. Lacktman

    Tampa 813.225.4127

    Related Insights

    View All Posts
    July 22, 2025 Health Care Law Today

    GLP-1 Receptor Agonists: Clinical Trial Considerations

    The U.S. Food & Drug Administration (FDA) has approved certain GLP-1 drugs for commercialization and use, including liraglutide (Victoza®), semaglutide (Ozempic®, Wegovy®), and tirzepatide (Mounjaro®, Zepbound®).
    July 21, 2025 Energy Current

    DOE Announces Pilot Program to Build Advanced U.S. Nuclear Fuel Supply Lines: What You Need to Know Now

    Introduction Coming on the heels of its June 2025 announcement establishing a pilot program for reactor construction and operation in…
    July 21, 2025 Labor & Employment Law Perspectives

    Considering a Reduction in Force? Some Preliminary Considerations

    Employers sometimes find it necessary to make the difficult decision to undergo a reduction-in-force (RIF), resulting in employee layoffs…